Patents by Inventor Jon Oscherwitz

Jon Oscherwitz has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Treatment of staphylococcal disorders
    Patent number: 12065485
    Abstract: Materials and methods are provided for treatment and/or prevention of Staphylococcal diseases and disorders such as infection and dermal inflammation.
    Type: Grant
    Filed: October 22, 2021
    Date of Patent: August 20, 2024
    Assignee: THE REGENTS OF THE UNIVERSITY OF MICHIGAN
    Inventors: Gabriel Nunez, Jon Oscherwitz, Kemp Cease, Yumi Nakamura, Tyler Nygaard
  • TREATMENT OF STAPHYLOCOCCAL DISORDERS
    Publication number: 20220048979
    Abstract: Materials and methods are provided for treatment and/or prevention of Staphylococcal diseases and disorders such as infection and dermal inflammation.
    Type: Application
    Filed: October 22, 2021
    Publication date: February 17, 2022
    Inventors: Gabriel Nunez, Jon Oscherwitz, Kemp Cease, Yumi Nakamura, Tyler Nygaard
  • Treatment of staphylococcal disorders
    Patent number: 11198724
    Abstract: Materials and methods are provided for treatment and/or prevention of Staphylococcal diseases and disorders such as infection and dermal inflammation.
    Type: Grant
    Filed: March 14, 2014
    Date of Patent: December 14, 2021
    Assignee: THE REGENTS OF THE UNIVERSITY OF MICHIGAN
    Inventors: Gabriel Nunez, Jon Oscherwitz, Kemp Cease, Yumi Nakamura, Tyler Nygaard
  • materials and methods
    Patent number: 10596245
    Abstract: The disclosure generally relates to the field of prevention and treatment of Staphylococcus aureus infections. In particular, the disclosure relates to immunogens comprising Staphylococcus aureus antigens and methods for generating immune responses to immunogens, and to antibody products specific for the Staphylococcus aureus epitopes and methods for treating Staphylococcus aureus infection with the antibody products.
    Type: Grant
    Filed: September 19, 2018
    Date of Patent: March 24, 2020
    Assignee: THE REGENTS OF THE UNIVERSITY OF MICHIGAN
    Inventors: Jon Oscherwitz, Kemp Cease
  • STAPHYLOCOCCUS AUREUS MATERIALS AND METHODS
    Publication number: 20190000951
    Abstract: The disclosure generally relates to the field of prevention and treatment of Staphylococcus aureus infections. In particular, the disclosure relates to immunogens comprising Staphylococcus aureus antigens and methods for generating immune reponses to immunogens, and to antibody products specific for the Staphylococcus aureus epitopes and methods for treating Staphylococcus aureus infection with the antibody products.
    Type: Application
    Filed: September 19, 2018
    Publication date: January 3, 2019
    Inventors: Jon Oscherwitz, Kemp Cease
  • materials and methods
    Patent number: 10080790
    Abstract: The disclosure generally relates to the field of prevention and treatment of Staphylococcus aureus infections. In particular, the disclosure relates to immunogens comprising Staphylococcus aureus antigens and methods for generating immune responses to immunogens, and to antibody products specific for the Staphylococcus aureus epitopes and methods for treating Staphylococcus aureus infection with the antibody products.
    Type: Grant
    Filed: September 17, 2015
    Date of Patent: September 25, 2018
    Assignee: THE REGENTS OF THE UNIVERSITY OF MICHIGAN
    Inventors: Jon Oscherwitz, Kemp Cease
  • STAPHYLOCOCCUS AUREUS MATERIALS AND METHODS
    Publication number: 20170246284
    Abstract: The disclosure generally relates to the field of prevention and treatment of Staphylococcus aureus infections. In particular, the disclosure relates to immunogens comprising Staphylococcus aureus antigens and methods for generating immune responses to immunogens, and to antibody products specific for the Staphylococcus aureus epitopes and methods for treating Staphylococcus aureus infection with the antibody products.
    Type: Application
    Filed: September 17, 2015
    Publication date: August 31, 2017
    Inventors: Jon Oscherwitz, Kemp Cease
  • TREATMENT OF STAPHYLOCOCCAL DISORDERS
    Publication number: 20160031973
    Abstract: Materials and methods are provided for treatment and/or prevention of Staphylococcal diseases and disorders such as infection and dermal inflammation.
    Type: Application
    Filed: March 14, 2014
    Publication date: February 4, 2016
    Applicant: The Regents of the University of Michigan
    Inventors: Gabriel Nunez, Jon Oscherwitz, Kemp Cease, Yumi Nakamura, Tyler Nygaard
  • EPITOPE-TARGETED ANTHRAX VACCINE
    Publication number: 20110256172
    Abstract: Anthrax vaccine compositions comprise a segment of a PA toxin protein that stimulates a B cell immune response specific for a defined epitope on the protective antigen of B. anthracis, a pharmaceutical excipient and optionally, one or more other protein segments comprising epitopes that augment the B cell response by stimulating a T cell immune response. The pharmaceutical compositions are useful for vaccinating individuals so as to confer protection from disease caused by B. anthracis including anthrax disease resulting from anthrax spore inhalation.
    Type: Application
    Filed: October 14, 2009
    Publication date: October 20, 2011
    Applicant: THE REGENTS OF THE UNIVERSITY OF MICHIGAN
    Inventors: Kemp B. Cease, Jon Oscherwitz